Image-Guided Drug Delivery Market Size is valued at US$ 58.9 Mn in 2024 and is predicted to reach US$ 687.4 Mn by the year 2034 at an 28.1% CAGR during the forecast period for 2025-2034.
Image-guided drug delivery (IGDD) is a novel clinical approach that maximises therapeutic efficacy, safety, and accuracy by integrating targeted drug delivery with imaging modalities. Imaging techniques, such as computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI), or ultrasound, are employed to observe in real-time inside organs and tissues.
This reduces exposure to normal tissues while allowing physicians to control and guide the administration of therapeutic agents directly to the site of disease, such as a tumour or infected organ. The image-guided drug delivery market is experiencing rapid growth, driven by advancements in medical technology and an increasing demand for precision medicine.
The rising incidence of cancer and neurological conditions is another important factor for the growth of the image-guided drug delivery market. The World Health Organization (WHO) reports that neurological disorders are quickly emerging as a significant public health concern, and cancer is the second greatest cause of death worldwide.
For both of these disorders, targeted therapy is made possible by image-guided drug delivery, which holds great promise for enhancing patient outcomes. Furthermore, advancements in MRI, CT, and PET technologies have enhanced the effectiveness and reliability of this drug administration approach. Additionally, as the population ages and more people suffer from lifestyle-related ailments, there is a greater need for advanced diagnostic and treatment methods. As a result, image-guided drug delivery is being used more often in medical facilities.
Some of the Key Players in Image-Guided Drug Delivery Market:
· ClearPoint Neuro, Inc.
· AiM Medical Robotics
· TriSalus Life Sciences
· RenovoRx Inc.
· Renishaw plc.
· Occam Design
· Infuseon Therapeutics Inc
· Neurochase
· GE HealthCare
· Koninklijke Philips N.V.
The image-guided drug delivery market is segmented by technology type, application, and end-use. By technology type, the market is segmented into drug-delivery systems and image-guided platforms. By application, the market is segmented into oncology, neurology, and others. By end-use, the market is segmented into hospitals, pharmaceutical & biotechnology companies, research institutes & universities, and contract research organizations (CROS).
In 2024, the image-guided drug delivery market was dominated by the oncology segment. The global increase in cancer diagnoses is driving the desire for precise, minimally invasive treatment modalities. The WHO estimates that the number of new cancer cases will rise by 60% annually over the next 20 years, reaching an estimated 29.5 million new cases by 2040. Ablative and targeted radiation therapy are made possible by image-guided drug delivery, which preserves healthy tissue. Furthermore, intra-procedure tumor imaging has been enhanced by the development of new real-time imaging equipment, particularly the combination of MRI, CT, and PET with real-time fluoroscopy or ultrasound.
The hospitals category led the global image-guided drug delivery market in 2024. With their hybrid operating rooms, cutting-edge imaging technologies, and dedicated neurosurgery and oncology teams, hospitals remain the primary locations for the introduction of image-guided drug delivery. Their dominance is supported by their capacity to perform intricate, high-volume procedures, such as liver-directed cancer therapy and intracranial infusions. As additional next-generation medications become available for clinical use, acceptance is anticipated to increase. Additionally, hospitals gain from multidisciplinary expertise and robust reimbursement policies. These benefits, combined with an emphasis on minimally invasive techniques, guarantee that hospitals will continue to be the world's leading users of image-guided drug delivery systems.
In 2024, the North American region led the image-guided drug delivery (IGDD) market due to significant investments in precision medicine, advanced healthcare infrastructure, and technological advancements. The region is advantageous due to the presence of prominent pharmaceutical companies, imaging technology firms, and research centres that are engaged in developing integrated drug-delivery systems. The demand for minimally invasive and image-guided treatment has risen because of the high incidence of chronic illnesses such as cancer, neurological disorders, and cardiovascular disease.
In addition, the image-guided drug delivery market is expected to increase significantly in the Asia-Pacific region due to the ageing population. Furthermore, it is projected that the region's image-guided therapy market will expand in the coming years due to the rising incidence of target diseases and the improvement of healthcare infrastructure. Additionally, during the forecast period, the region's image-guided drug delivery market is expected to grow at a faster rate due to the rapid acceptance of advanced radiation therapies and technological advancements.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 58.9 Mn |
|
Revenue Forecast In 2034 |
USD 687.4 Mn |
|
Growth Rate CAGR |
CAGR of 28.1% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Technology Type, By Application, By End-use, and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; Germany; The UK; France; Italy; Spain; Rest of Europe; China; Japan; India; South Korea; Southeast Asia; Rest of Asia Pacific; Brazil; Argentina; Mexico; Rest of Latin America; GCC Countries; South Africa; Rest of the Middle East and Africa |
|
Competitive Landscape |
ClearPoint Neuro, Inc., AiM Medical Robotics, TriSalus Life Sciences, RenovoRx Inc., Renishaw plc., Occam Design, Infuseon Therapeutics Inc, Neurochase, GE HealthCare, and Koninklijke Philips N.V. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Image-Guided Drug Delivery Market Snapshot
Chapter 4. Global Image-Guided Drug Delivery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on Image-Guided Drug Delivery Market Industry Trends
4.10. Global Image-Guided Drug Delivery Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
Chapter 5. Image-Guided Drug Delivery Market Segmentation 1: By Technology Type, Estimates & Trend Analysis
5.1. Market Share by Technology Type, 2025 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology Type:
5.2.1. Drug-Delivery Systems
5.2.2. Image-Guided Platforms
Chapter 6. Image-Guided Drug Delivery Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2025 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Others
Chapter 7. Image-Guided Drug Delivery Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2025 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
7.2.1. Hospitals
7.2.2. Pharmaceutical & Biotechnology Companies
7.2.3. Contract Research Organizations (CROs)
7.2.4. Research Institutes & Universities
Chapter 8. Image-Guided Drug Delivery Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Image-Guided Drug Delivery Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
8.2.3. North America High-Altitude Oxygen Simulation Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.3. Europe
8.3.1. Europe Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
8.3.3. Europe Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
8.4.3. Asia Pacific Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.5. Latin America
8.5.1. Latin America Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
8.5.3. Latin America Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
8.6.3. Middle East & Africa Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Image-Guided Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ClearPoint Neuro, Inc.
9.2.1.1. Business Overview
9.2.1.2. Key Product /Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. TriSalus Life Sciences, Inc.
9.2.3. GE Healthcare
9.2.4. Koninklijke Philips N.V.
9.2.5. RenovoRx Inc.
Image-Guided Drug Delivery Market by Technology Type-
· Drug-Delivery Systems
· Image-Guided Platforms
Image-Guided Drug Delivery Market by Application-
· Oncology
· Neurology
· Others
Image-Guided Drug Delivery Market by End-use-
· Hospitals
· Pharmaceutical & Biotechnology Companies
· Research Institutes & Universities
· Contract Research Organizations (CROs)
Image-Guided Drug Delivery Market by Region-
North America-
· The US
· Canada
Europe-
· Germany
· The UK
· France
· Italy
· Spain
· Rest of Europe
Asia-Pacific-
· China
· Japan
· India
· South Korea
· Southeast Asia
· Rest of Asia Pacific
Latin America-
· Brazil
· Argentina
· Mexico
· Rest of Latin America
Middle East & Africa-
· GCC Countries
· South Africa
· Rest of the Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
